Versant Vantage I, L.P. insider trades: LAVA Therapeutics (LVTX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Versant Vantage I, L.P. reports to the SEC
and 4 more companies
Open-market buys and sales
46 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 19, 2025 | LVTX | ↓ Sell | 2,370,533 | $1.40 | $3.3M | Direct | Sep 23, 2025 (4d) |
| Sep 19, 2025 | LVTX | ↓ Sell | 532,870 | $1.40 | $747K | Indirect | Sep 23, 2025 (4d) |
| Sep 18, 2025 | LVTX | ↓ Sell | 1,036,624 | $1.49 | $1.5M | Direct | Sep 18, 2025 (0d) |
| Sep 18, 2025 | LVTX | ↓ Sell | 647,810 | $1.49 | $962K | Indirect | Sep 18, 2025 (0d) |
| Oct 29, 2024 | GLUE | ↓ Sell | 157,895 | $9.44 | $1.5M | Indirect | Oct 30, 2024 (1d) |
| Sep 20, 2024 | GLUE | ↓ Sell | 1,132,566 | $6.53 | $7.4M | Direct | Sep 24, 2024 (4d) |
| Sep 13, 2024 | GLUE | ↓ Sell | 567,213 | $6.00 | $3.4M | Direct | Sep 13, 2024 (0d) |
| Aug 28, 2024 | BDTX | ↓ Sell | 221,600 | $6.32 | $1.4M | Direct | Aug 30, 2024 (2d) |
| Jun 3, 2022 | RPTX | ↓ Sell | 750,000 | $12.25 | $9.2M | Indirect | Jun 7, 2022 (4d) |
| Oct 18, 2021 | OYST | ↓ Sell | 550,000 | $14.84 | $8.2M | Indirect | Oct 20, 2021 (2d) |
| Jun 28, 2021 | GLUE | ↑ Buy | 157,895 | $19.00 | $3.0M | By Versant Vantage I, L.P. | Jun 30, 2021 (2d) |
| Nov 30, 2020 | BDTX | ↓ Sell | 10,393 | $33.15 | $345K | Indirect | Dec 1, 2020 (1d) |
| Nov 19, 2020 | BDTX | ↓ Sell | 114,854 | $33.01 | $3.8M | Direct | Nov 23, 2020 (4d) |
| Nov 19, 2020 | BDTX | ↓ Sell | 15,163 | $33.01 | $501K | Indirect | Nov 23, 2020 (4d) |
| Nov 18, 2020 | BDTX | ↓ Sell | 4,178 | $33.05 | $138K | Direct | Nov 19, 2020 (1d) |
| Nov 18, 2020 | BDTX | ↓ Sell | 552 | $33.05 | $18K | Indirect | Nov 19, 2020 (1d) |
| Nov 16, 2020 | BDTX | ↓ Sell | 4,152 | $33.74 | $140K | Direct | Nov 17, 2020 (1d) |
| Nov 16, 2020 | BDTX | ↓ Sell | 548 | $33.74 | $18K | Indirect | Nov 17, 2020 (1d) |
| Nov 12, 2020 | BDTX | ↓ Sell | 13,779 | $34.15 | $471K | Direct | Nov 13, 2020 (1d) |
| Nov 12, 2020 | BDTX | ↓ Sell | 1,819 | $34.15 | $62K | Indirect | Nov 13, 2020 (1d) |
| Nov 11, 2020 | BDTX | ↓ Sell | 34,967 | $34.11 | $1.2M | Direct | Nov 12, 2020 (1d) |
| Nov 11, 2020 | BDTX | ↓ Sell | 4,616 | $34.11 | $157K | Indirect | Nov 12, 2020 (1d) |
| Nov 9, 2020 | BDTX | ↓ Sell | 8,303 | $33.08 | $275K | Direct | Nov 10, 2020 (1d) |
| Nov 9, 2020 | BDTX | ↓ Sell | 1,097 | $33.08 | $36K | Indirect | Nov 10, 2020 (1d) |
| Nov 5, 2020 | BDTX | ↓ Sell | 10,024 | $33.14 | $332K | Direct | Nov 6, 2020 (1d) |
| Nov 5, 2020 | BDTX | ↓ Sell | 1,324 | $33.14 | $44K | Indirect | Nov 6, 2020 (1d) |
| Oct 27, 2020 | BDTX | ↓ Sell | 7,865 | $33.28 | $262K | Direct | Oct 28, 2020 (1d) |
| Oct 27, 2020 | BDTX | ↓ Sell | 1,038 | $33.28 | $35K | Indirect | Oct 28, 2020 (1d) |
| Oct 20, 2020 | ALGS | ↑ Buy | 200,000 | $15.00 | $3.0M | Indirect | Oct 20, 2020 (0d) |
| Oct 19, 2020 | BDTX | ↓ Sell | 13,909 | $33.44 | $465K | Direct | Oct 20, 2020 (1d) |
| Oct 19, 2020 | BDTX | ↓ Sell | 1,837 | $33.44 | $61K | Indirect | Oct 20, 2020 (1d) |
| Oct 14, 2020 | BDTX | ↓ Sell | 15,229 | $33.30 | $507K | Direct | Oct 15, 2020 (1d) |
| Oct 14, 2020 | BDTX | ↓ Sell | 2,011 | $33.30 | $67K | Indirect | Oct 15, 2020 (1d) |
| Oct 12, 2020 | BDTX | ↓ Sell | 19,986 | $33.50 | $670K | Direct | Oct 13, 2020 (1d) |
| Oct 12, 2020 | BDTX | ↓ Sell | 2,639 | $33.50 | $88K | Indirect | Oct 13, 2020 (1d) |
| Oct 7, 2020 | BDTX | ↓ Sell | 40,570 | $33.44 | $1.4M | Direct | Oct 8, 2020 (1d) |
| Oct 7, 2020 | BDTX | ↓ Sell | 5,356 | $33.44 | $179K | Indirect | Oct 8, 2020 (1d) |
| Aug 11, 2020 | BDTX | ↓ Sell | 12,184 | $33.06 | $403K | Direct | Aug 12, 2020 (1d) |
| Aug 11, 2020 | BDTX | ↓ Sell | 1,608 | $33.06 | $53K | Indirect | Aug 12, 2020 (1d) |
| Jun 23, 2020 | RPTX | ↑ Buy | 250,000 | $20.00 | $5.0M | Indirect | Jun 25, 2020 (2d) |
| Mar 3, 2020 | PASG | ↑ Buy | 225,000 | $18.00 | $4.0M | By Versant Vantage I, L.P. | Mar 3, 2020 (0d) |
| Feb 3, 2020 | BDTX | ↑ Buy | 498,654 | $19.00 | $9.5M | Indirect | Feb 5, 2020 (2d) |
| Feb 3, 2020 | BDTX | ↑ Buy | 396,082 | $19.00 | $7.5M | Direct | Feb 5, 2020 (2d) |
| Nov 4, 2019 | OYST | ↑ Buy | 465,000 | $16.00 | $7.4M | Indirect | Nov 4, 2019 (0d) |
| Nov 4, 2019 | OYST | ↑ Buy | 125,000 | $16.00 | $2.0M | Direct | Nov 4, 2019 (0d) |
| Oct 7, 2019 | APRE | ↑ Buy | 333,333 | $15.00 | $5.0M | Direct | Oct 7, 2019 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Versant Vantage I, L.P.'s insider trades
Versant Vantage I, L.P. is an insider at LAVA Therapeutics (LVTX). Since Oct 7, 2019, it has reported 9 open-market purchases worth $46.5M and 37 sales worth $49.3M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include other transactions (25 filings), conversions (9 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every LVTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.